1. FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
   Meng Xie et al, 2023, Journal of Hepatology CrossRef
2. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling
   Najah Albadari et al, 2024, Frontiers in Pharmacology CrossRef
3. Design, synthesis and biological evaluation of quinazoline derivatives as potent and selective FGFR4 inhibitors
   Chenghao Pan et al, 2021, European Journal of Medicinal Chemistry CrossRef
4. Exploring the Pharmacological Mechanism of the Herb Pair “HuangLian-GanJiang” against Colorectal Cancer Based on Network Pharmacology
   Benjiao Gong et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
5. Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer
   Yanwei Ye et al, 2020, International Journal of Oncology CrossRef
6. Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine
   Xue Zhu et al, 2022, Frontiers in Pharmacology CrossRef
7. Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
   Yanan Liu et al, 2021, Frontiers in Pharmacology CrossRef
8. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer
   Xing Zhang et al, 2022, Gastroenterology CrossRef
9. Characterization of FGF401 as a reversible covalent inhibitor of fibroblast growth factor receptor 4
   Zhan Zhou et al, 2019, Chemical Communications CrossRef